These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31511820)

  • 41. Trends in Demographics, Hospitalization Outcomes, Comorbidities, and Mortality Risk among Systemic Sclerosis Patients.
    Amoda O; Ravat V; Datta S; Saroha B; Patel RS
    Cureus; 2018 May; 10(5):e2628. PubMed ID: 30027020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recreational Marijuana Use and Acute Myocardial Infarction: Insights from Nationwide Inpatient Sample in the United States.
    Desai R; Patel U; Sharma S; Amin P; Bhuva R; Patel MS; Sharma N; Shah M; Patel S; Savani S; Batra N; Kumar G
    Cureus; 2017 Nov; 9(11):e1816. PubMed ID: 29312837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
    Lee C; Greene SL; Wong A
    Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
    [No Abstract]   [Full Text] [Related]  

  • 44. Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review.
    Beech RA; Sterrett DR; Babiuk J; Fung H
    J Oral Maxillofac Surg; 2015 Oct; 73(10):1907-10. PubMed ID: 25896565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
    Richards JR
    J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
    Butterworth P; Slade T; Degenhardt L
    Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder.
    Lagerberg TV; Icick R; Andreassen OA; Ringen PA; Etain B; Aas M; Henry C; Bjella TD; Melle I; Bellivier F
    J Affect Disord; 2016 Jan; 190():286-293. PubMed ID: 26544611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].
    Kazour F; Awaida C; Souaiby L; Richa S
    Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
    Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
    Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
    [No Abstract]   [Full Text] [Related]  

  • 51. Cannabinoid hyperemesis syndrome: a case series and review of previous reports.
    Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B
    Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Demographics and Hospital Outcomes in American Women With Endometriosis and Psychiatric Comorbidities.
    Robert CA; Caraballo-Rivera EJ; Isola S; Oraka K; Akter S; Verma S; Patel RS
    Cureus; 2020 Aug; 12(8):e9935. PubMed ID: 32968596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabinoid hyperemesis syndrome.
    Heise L
    Adv Emerg Nurs J; 2015; 37(2):95-101. PubMed ID: 25929220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent trends in cyclic vomiting syndrome-associated hospitalisations with liberalisation of cannabis use in the state of Colorado.
    Bhandari S; Jha P; Lisdahl KM; Hillard CJ; Venkatesan T
    Intern Med J; 2019 May; 49(5):649-655. PubMed ID: 30426628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect.
    Figueroa-Rivera IM; Estremera-Marcial R; Sierra-Mercado M; Gutiérrez-Núñez J; Toro DH
    Case Rep Gastrointest Med; 2015; 2015():405238. PubMed ID: 26266060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developmental pathways from prenatal marijuana exposure to Cannabis Use Disorder in young adulthood.
    Sonon K; Richardson GA; Cornelius J; Kim KH; Day NL
    Neurotoxicol Teratol; 2016; 58():46-52. PubMed ID: 27208888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain.
    Hefner K; Sofuoglu M; Rosenheck R
    Am J Addict; 2015 Sep; 24(6):538-45. PubMed ID: 26246069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Racial and gender-based disparities and trends in common psychiatric conditions in liver cirrhosis hospitalizations: A ten-year United States study.
    Patel P; Ali H; Inayat F; Pamarthy R; Giammarino A; Ilyas F; Smith-Martinez LA; Satapathy SK
    World J Hepatol; 2023 Feb; 15(2):289-302. PubMed ID: 36926245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B
    Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.